Versus Arthritis: Quality improvement in rheumatology practice: Delivering change for patients
Monday, 07 Jun 2021
| Funding Deadline
Versus Arthritis are collaborating with Pfizer UK to offer a new competitive funding opportunity focused on improving patient care and outcomes in rheumatology. Proposals should address gaps in the appropriate management of one or more of: rheumatoid arthritis; psoriatic arthritis; juvenile idiopathic arthritis; axial spondyloarthritis.
Of particular interest are proposals that:
- Focus on the improvement of patient care, patient experience and improved outcomes aiming at systematic and continuous actions that lead to measurable improvement in health care services and the health status of individuals and targeted patient groups in rheumatology.
- Improve services and pathways for people with chronic inflammatory arthritis conditions with the aim of improving people’s quality of life, ability to self-manage (such as self-efficacy, patient activation), co-morbidities, and overall patient experience.
- Proposals which will have the highest chance of making a difference to the lives of people with arthritis.
Deadline for proposals: 7 June 2021
Find out more here